[FULL] THE DAILY REPORT : S. Korea authorizes Pfizer's oral COVID-19 treatment for emergency use

▪ S. Korea authorizes Pfizer's oral COVID-19 treatment for emergency use ▪ N. Korea reportedly shows interest in securing U.S.-made COVID-19 vaccines ▪ Accumulated net stock purchases by S. Korean retail investors hit record high in 2021 ▪ President Moon hosts luncheon with heads of S. Korea's conglomerates, including Samsung ▪ Book Trends 2021: Books that have been popular this year ▪ AI robots improve contactless customer experience in S. Korean museums ▪ World News: South Africa's Archbishop Desmond Tutu dies aged 90 ▪ A POTENTIAL GAME-CHANGER? (We sit down with our panel of expert to discuss the potential role that COVID-19 treatment pills could play in our global fight against the pandemic, with health authorities pinning high hopes on these oral drugs to turn the tide of our fortunes.) 전 세계적인 코로나19 재확산 속에서 먹는 치료제 시대가 다가왔다. 미국이 먹는 치료제 2종에 대해 긴급사용 승인을 내린 데 이어, 한국 역시, 먹는 치료제 도입이 가시권에 들어왔는데, 먹는 치료제가 각국 방역 상황과 치료에 어떤 변화를 가져올지 전문가들과 이야기 나눠보겠다. #COVID19 #Korea #SocialDistancing #OmicronVariant #US #COVID19Drugs #Paxlovid #Molnupiravir #DavidKwak #SohnHoJoon #DrPeterChinHong #코로나19 #한국 #방역지침 #거리두기 #오미크론변이 #변이바이러스 #미국 #먹는치료제 #곽영환 #손호준 #DrPeterCHINHONG 2021-12-27, 14:00 (KST)